Panavance to Present at the BIO Investor Forum

Panavance Therapeutics

BERWYN, PA — Panavance Therapeutics Inc. announced it will present at the BIO Investor Forum on Tuesday, October 17 at 10 a.m. PT.

Greg Bosch, Chairman and CEO will present an overview of Panavance and update on the development of Panavance’s lead product candidate, misetionamide, a highly selective yet broadly active cancer therapeutic with a unique mechanism of action that suppresses cancer by disrupting its energy metabolism, leading to cancer cell death through a number of validated mechanisms. A Phase 1 study is currently recruiting in pancreatic cancer. Greg will share Panavance’s recent accomplishments and its upcoming planned milestones.

Presentation Details:

Date: Tuesday, October 17, 2023
Time: 10:00 AM (Pacific Time)
Location: Hilton San Francisco Union Square, Franciscan C Room

The BIO Investor Forum will take place on October 17-18 in San Francisco, CA.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Pennsylvania Department of Aging Hosts Inaugural Volunteer Conference to Strengthen Aging Network